Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines.

BMC cancer - 18 Jun 2010

Xu Ling, Hausmann Martin, Dietmaier Wolfgang, Kellermeier Silvia, Pesch Theresa, Stieber-Gunckel Manuela, Lippert Elisabeth, Klebl Frank, Rogler Gerhard

Abstract excerpt

BACKGROUND: Cholangiocarcinoma (CC) is a malignant neoplasm of the bile ducts or the gallbladder. Targeting of growth factor receptors showed therapeutic potential in palliative settings for many solid tumors. The aim of this study was to determine the expression of seven growth factor receptors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bile Duct Neoplasms
Share to Bile Ducts, Intrahepatic
Share to Cetuximab

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholangiocarcinoma

Share to Proto-Oncogene Proteins c-met

Share to Receptors, Growth Factor

Share to Receptors, Somatomedin

Share to Receptors, Vascular Endothelial Growth Factor

Source

Open in PubMed Open full text

Identifiers

PMID: 20565817
DOI: 10.1186/1471-2407-10-302
PMCID: PMC2896958

Genes

EGFR
KRAS

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20565817-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines.PMID 20565817Read ↗

Characterization of EGFR family gene aberrations in cholangiocarcinomaSemantic proximity Read ↗

Analysis of Epidermal Growth Factor Receptor (EGFR) Expression and Amplification in Cholangiocarcinoma and Correlation with Histological TypesSemantic proximity Read ↗

Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.Semantic proximity Read ↗

Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumoursSemantic proximity Read ↗

The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III.Semantic proximity Read ↗

Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan.Semantic proximity Read ↗

Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.Semantic proximity Read ↗

Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18-21 mutations.Semantic proximity Read ↗

The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma.Semantic proximity Read ↗

No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver TumorsSemantic proximity Read ↗

Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells.Semantic proximity Read ↗

Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: a phase 2 study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.